Nucala
Drug timelines are a Plus or Pro feature.
44 regulatory and trial events tracked for Nucala, covering 2015-11-04 to 2026-08-19. Get the full timeline:
Most recent: EMA Authorised: Nucala (Mepolizumab) — GlaxoSmithKline Trading Services Limited